Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer

Fig. 3

Chemotherapy efficacy and prognostic significance of CMTM1_v17 expression in patients with NAC treatment. a PR rates were higher in patients with CMTM1_v17 low expression than those with CMTM1_v17 high expression. b, c Patients with low expression of CMTM1_v17 had significantly better DFS and OS compared to those with high expression of CMTM1_v17 after NAC. NAC neoadjuvant chemotherapy; PR partial response; OS overall survival; DFS disease-free survival

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us